Company / Total Debt
ENDONOVO THERAPEUTICS, INC. Total Debt History
FY2014-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$7.2M
FY2022
5-year range
$6.8M / $8.2M
FY2018-FY2022
Trend
-1.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Debt has fluctuated over the past 8 years, ranging from $28,647 in FY2015 to $8M in FY2018.
Based on SEC 10-K filings.
$7M in FY2022 with a 3-year CAGR of +1.3%.
Increased from $7M to $7M over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- +1.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +1.3%, indicating consistent growth.
- In FY2022, total debt decreased 1.4% year-over-year.
- Peak total debt was recorded in FY2018.
- Lowest total debt in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $7.2M | -1.4% |
| FY2021 | $7.3M | +6.2% |
| FY2020 | $6.8M | -0.6% |
| FY2019 | $6.9M | -15.7% |
| FY2018 | $8.2M | +155.5% |
| FY2016 | $3.2M | +11048.3% |
| FY2015 | $28.6K | -98.2% |
| FY2014 | $1.6M | - |
| FY2011 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026